Cognitive Function Clinical Trial
— SHARP-POfficial title:
Seniors Health and Activity Research Program-Pilot
Verified date | December 2017 |
Source | Wake Forest University Health Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this pilot study is to develop and conduct well-designed trial to assess whether a multi-factorial intervention involving physical activity and cognitive training reduces the risk of significant cognitive decline in older individuals.
Status | Completed |
Enrollment | 73 |
Est. completion date | June 30, 2010 |
Est. primary completion date | June 30, 2009 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 70 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Age 70 to 85 years - Summary score between 88 (80 for less than 8 years of education) and 95 on the Modified Mini-Mental Exam - Sedentary lifestyle, i.e., not actively participating in a formal exercise program within the past 3 months (defined as 30 minutes or more of formal exercise at least once a week; brisk walks will be considered formal exercise, leisurely walks will not) - Fluency in standard American English (to limit staffing and translation costs in this pilot) - Willingness to be randomized to any of the four intervention conditions Exclusion Criteria: - Failure to provide the name of a personal physician - Living in a nursing home; persons living in assisted or independent housing will not be excluded - Unable to communicate because of severe hearing loss or speech disorder - Severe visual impairment, which would preclude completion of the assessments and/or intervention - Neurologic disease, e.g. Alzheimer's (or other types of dementia), stroke that required hospitalization, Parkinson's, multiple sclerosis, amyotrophic lateral sclerosis, or prior diagnosis of mild cognitive impairment (MCI) - Abnormal functioning based on the modified Telephone Interview for Cognitive Status (less than 30) - Positive screen for MCI or dementia - Scores greater than or equal to 1.5 standard deviations below normal on memory and non-memory domain tests (speed of processing, and verbal fluency) - Severe rheumatologic or orthopedic diseases, e.g., awaiting joint replacement, active inflammatory disease - Terminal illness with life expectancy less than 8 months, as determined by a physician - Severe pulmonary disease, e.g., on home oxygen or chronic steroids - Severe cardiac disease, including New York Health Association Class III or IV congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest which required resuscitation, use of a cardiac defibrillator, or uncontrolled angina - Other significant co-morbid disease that would impair ability to participate in the exercise-based intervention, e.g. renal failure on hemodialysis, severe or acute psychiatric disorder (e.g. bipolar disorder or major depression, schizophrenia), excessive alcohol use (more than 14 drinks per wk); persons with managed depression (on stable dosage for at least 3 months) will not be excluded - Baseline Geriatric Depression Scale score greater than 6 - Other significant factors that may affect the ability for cognitive training, including a history of head trauma resulting in a loss of consciousness, current use of benzodiazepines, hypnotic or anticholinergic agents, and current use of cognitive enhancing prescription or investigational medications (e.g., donepezil, selegiline, tacrine) - Member of household is already enrolled - Lives distant from the study site or is planning to move out of the area in next 3 years or leave the area for more than 3 months during the next year - History of participation in a cognitive program in the last 2 years (includes research studies involving memory training) - Myocardial infarction, coronary artery bypass graft, or valve replacement within past 6 months - Serious conduction disorder (e.g., 3rd degree heart block), uncontrolled arrhythmia - Pulmonary embolism or deep venous thrombosis within past 6 months - Stroke, hip fracture, hip or knee replacement, or spinal surgery within past 4 months - Receiving physical therapy for gait, balance, or other lower extremity training - Severe hypertension, e.g., systolic blood pressure over 160 mmHg, diastolic blood pressure over 110 mmHg - Other temporary intervening events, such as sick spouse, bereavement, or recent move - Participation in another intervention trial; participation in an observational study may be permitted - Inability to commit to intervention schedule requirements |
Country | Name | City | State |
---|---|---|---|
United States | Wake Forest University Health Sciences | Winston-Salem | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Wake Forest University Health Sciences | National Institute on Aging (NIA) |
United States,
Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci. 2003 Mar;14(2):125-30. — View Citation
Espeland MA, Katula JA, Rushing J, Kramer AF, Jennings JM, Sink KM, Nadkarni NK, Reid KF, Castro CM, Church T, Kerwin DR, Williamson JD, Marottoli RA, Rushing S, Marsiske M, Rapp SR; LIFE Study Group. Performance of a computer-based assessment of cognitive function measures in two cohorts of seniors. Int J Geriatr Psychiatry. 2013 Dec;28(12):1239-50. doi: 10.1002/gps.3949. Epub 2013 Apr 16. — View Citation
Espeland MA, Rapp SR, Robertson J, Granek I, Murphy C, Albert M, Bassford T; Women's Health Initiative Memory Study. Benchmarks for designing two-stage studies using modified mini-mental state examinations: experience from the Women's Health Initiative Memory Study. Clin Trials. 2006;3(2):99-106. — View Citation
Legault C, Jennings JM, Katula JA, Dagenbach D, Gaussoin SA, Sink KM, Rapp SR, Rejeski WJ, Shumaker SA, Espeland MA; SHARP-P Study Group. Designing clinical trials for assessing the effects of cognitive training and physical activity interventions on cognitive outcomes: the Seniors Health and Activity Research Program Pilot (SHARP-P) study, a randomized controlled trial. BMC Geriatr. 2011 May 26;11:27. doi: 10.1186/1471-2318-11-27. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Composite Cognitive Function in Z-scores (i.e. Which Converts Raw Data to Standard Deviation (SD) Units: [Score-mean]/SD]). This Composite is Formed by Averaging the Z-scores From Individual Tests. | 6 measures of executive functioning: Self-Ordered Pointing task (24): working memory 1- and 2-Back tests (25-26): working memory Eriksen flanker (27): response inhibition Task Switching (28): attentional flexibility Trail Making (29): executive function z-score=(raw score-mean)/standard deviation 4 measures of episodic memory Hopkins Verbal Learning Test (30) Wechsler Memory Scale-III (31) A composite of 10 scores: dividing each's difference from the baseline mean by the baseline SD, averaging the 6 executive function and 4 episodic memory z-transformed measures, and norming to have SD 1. 24. Petrides. Neuropsych 1982;20:249-62. 25. Dobbs. Psychol Aging 1989;4:500-3. 26. Jonides. J Cog Neurosci 1997;9:462-75. 27. Ericksen. Br J Sports Med 2009;43:22-4. 28. Kramer. Acta Psychologica 1999;101:339-78. 29. Reitan. Per Motor Skills 1958;8:271-6. 30. Brandt. Clin Neuropsych 1991;5:125-42. 31. Wechsler D.1997. Psychological Corporation, Harcourt, Inc: San Antonio. |
Changes from baseline at 4 months in z-scores. | |
Secondary | Change in Executive Function: Z-score Formed by Averaging the Individual Z-scores From the Five Tests Listed Below. | Composite of 5 tasks: Self-Ordered Pointing Task of planning, working memory, and monitoring. Subjects view 16 abstract shapes and choose a shape so that each is selected by the 16th trial and none is chosen more than once. (Eriksen, Percept Psychophysiology 1974;16:143-49). N-Back Test of working memory. Subjects see individual letters and indicate whether the letter is the same as the nth back letter, with n equal to 1 and 2. (Dobbs, Psychol Aging 1989;4:500-3.) Eriksen flanker task of response incompatibility. Subjects see an arrow facing either right or left and indicate the direction.The target displays can be neutral congruent, or incongruent. (Eriksen, Percept Psychophys 1974;16:143-49.) Trail Making Test-Part B of alternating attention. Subjects connect 25 labeled circles and are scored by completion time. The lower the scores the better the performance. See details in the primary outcome. Raw scores for each test were converted to z-scores. |
Baseline to 4 months | |
Secondary | Composite Episodic Memory | Composite of 4 components. The Hopkins Verbal Learning Test (HVLT) of verbal learning. Subjects hear 12 words and repeat as many as possible. This is repeated twice for a total of 3 trials. 20 mins later the subject is asked to recall as many words as possible. Subjects also do a recognition trial with 24 words. Scores for immediate and delayed recall, and recognition are calculated.(Brandt J. Clin Neuropsych 1991;5:125-42). The Logical Memory (LM) test The LM test has 2 parts. In Part 1, subjects hear a story and recall as many pieces as possible immediately and after a 30 minute delay. Subjects receive a story unit score for accuracy of re-telling story details and a thematic score for recalling story themes. The higher the scores the better the performance. ( Wechsler D. The Wechsler Memory Scale-3rd Edition (WHM-III). Psycholog Corp, Harcourt, Inc.) Individual scores are converted to z-scores and averaged to form the composite. |
Change a 4 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT03708692 -
Menstrual Cycle Phases on Recovery and Cognitive Function
|
||
Active, not recruiting |
NCT04505345 -
Virtual Reality Cognitive Training in Alcohol Use Disorder
|
N/A | |
Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
Completed |
NCT02915913 -
Effects of Exercise Training on Cognitive Function and Neurotrophic Factors in Overweight Adults
|
N/A | |
Completed |
NCT01410097 -
Physical and Cognitive Function - Look AHEAD Ancillary Study
|
N/A | |
Completed |
NCT03826121 -
Efficacy and Safety of Sesame Oil Cake Extract on Improvement of Cognitive Function
|
N/A | |
Recruiting |
NCT05621278 -
Children to Adults Mental and Psychosomatic Health Study (CAMPS)
|
||
Completed |
NCT05498415 -
Feasibility, Acceptability, and Efficacy of the Sleep Move Stand Study
|
N/A | |
Completed |
NCT03208569 -
Anticholinergic Burden - Treatment Optimization
|
||
Completed |
NCT03793777 -
The Effect of Aronia Melanocarpa Extract on Cognitive Function
|
N/A | |
Recruiting |
NCT05525299 -
Reminiscence-Based Life Review on Copying With Existential Suffering Among Older Cancer Survivors
|
N/A | |
Completed |
NCT03698123 -
Performance Nutrition for Residents and Fellows
|
N/A | |
Completed |
NCT04543500 -
Self-regulation of Prefrontal Cortex During Emotional Cognitive Control
|
N/A | |
Recruiting |
NCT05891977 -
Effect of Tomato Paste Consumption on the Microbiota-gut-brain Axis in Healthy Adults
|
N/A | |
Recruiting |
NCT05591885 -
Nutrilite Memory Builder on the Improvement of Cognitive Function
|
N/A | |
Active, not recruiting |
NCT05575752 -
Acute Health Effects of High Temperature Exposure
|
N/A | |
Completed |
NCT03716609 -
Effects of Magnesium Supplementation on Hemodynamic Parameters and Cognitive Function
|
N/A | |
Completed |
NCT02763514 -
The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood
|
N/A | |
Completed |
NCT02675621 -
Investigation of Acute Mood and Cognitive Performance Effects of Beverages Containing Phenolics in Healthy Adults
|
N/A |